At Happiness Capital, we back bold ideas that drive real impact. That’s why we’re thrilled to announce our investment in Epoch Biodesign, a synthetic bio innovator reshaping how industries like textile, fashion and automotive recycle their plastic waste.

Founded in 2019 by Jacob Nathan, Epoch Biodesign harnesses synthetic biology, generative AI, and physics-based data modeling to engineer enzymes that break down stubborn plastic and textile waste. Their revolutionary platform deconstructs waste at the molecular level, purifies it, and rebuilds it into brand-new, high-performance polymers – offering a fully circular solution that rivals fossil-based materials in both performance and cost.

The urgency is clear: less than 1% of textile waste is recycled today. Traditional methods struggle with blended fabrics, chemical coatings, and synthetic fibers, dooming most textiles to landfills or incineration. Epoch Biodesign’s bio-recycling platform is a game-changer, scalable, cost-competitive, and ready to revolutionize the industry.

Epoch Biodesign have big plans to grow their team, launch the UK’s first bio-recycling demonstration facility and look to expand beyond nylon, extending their enzyme-powered platform to other plastics. Ultimately they’re aiming for a fully circular economy. By pushing global textile recycling rates from a dismal 1% toward near 100%, they aren’t just reducing waste – they’re redefining the future of materials.

Jacob Nathan, Founder of Epoch Biodesign, says: “Happiness Capital share our mission for real, scalable impact. Their deep industry connections and commitment to sustainability will help turn bio-recycling from a concept into a global reality.”

We are proud to support Epoch Biodesign in their mission to reinvent recycling. The future is here – and it’s built on science, innovation, and sustainability.

To learn more, visit www.epochbiodesign.com